Ivabradine Tablet, Film Coated
Product Images NDC 62332-679

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ivabradine (NDC 62332-679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ivabradine-5mg (Ivabradine 5mg)

Ivabradine-5mg (Ivabradine 5mg)
Each film-coated tablet contains 5 mg of ivabradine hydrochloride. These tablets are for oral use and should be stored at temperatures between 15°C to 30°C (59°F to 86°F). The packaging is child-resistant. Manufactured by Alembic Pharmaceuticals Limited in India for distribution by Alembic Pharmaceuticals, Inc. in the USA. This medication is dispensed in a package containing 60 film-coated tablets. Pharmacists are advised to provide patients with a Medication Guide.*
FDA Label Image

Ivabradine-7-5mg (Ivabradine 7 5mg)

Ivabradine-7-5mg (Ivabradine 7 5mg)
This text is a description of a medication called Ivabradine tablets. Each film-coated tablet contains 7.5 mg of ivabradine hydrochloride. It is recommended for oral use and should be stored at a temperature range of 15°C to 30°C. The package is child-resistant and contains 60 tablets. It is manufactured by Alembic Pharmaceuticals Limited in India and distributed by Alembic Pharmaceuticals, Inc. in the USA. The medication guide is provided for each patient, and the usual dose can be found in the package insert. For more information, one can visit the website or call the provided phone number.*
FDA Label Image

Ivabradine-fig2.jpg (Ivabradine Fig2)

Ivabradine-fig2.jpg (Ivabradine Fig2)
This text provides information on drug interactions and dosage adjustments based on the use of different medications. It lists changes due to strong and moderate CYP3A4 inhibitors, CYP3A4 inducers, and other specific medications like sildenafil, simvastatin, and omeprazole. Recommendations are given for each medication, including contraindications, avoiding use, and whether dose adjustments are necessary.*
FDA Label Image

Ivabradine-fig3.jpg (Ivabradine Fig3)

FDA Label Image

Ivabradine-figure4 (Ivabradine Figure4)

FDA Label Image

Ivabradine-structure.jpg (Ivabradine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.